Chemical Structure : LRG20
Catalog No.: PC-28804Not For Human Use, Lab Use Only.
LRG20 is a potent, orally bioavailable, CRBN-dependent GLI1 PROTAC degrader with DC50 of 16.93 nM and Dmax=91.1% in HT-29 colorectal cancer cells, preferentially degrading GLI1/GLI2 over GLI3 without obvious degradation of representative CRBN neo-substrates.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LRG20 is a potent, orally bioavailable, CRBN-dependent GLI1 PROTAC degrader with DC50 of 16.93 nM and Dmax=91.1% in HT-29 colorectal cancer cells, preferentially degrading GLI1/GLI2 over GLI3 without obvious degradation of representative CRBN neo-substrates.
LRG20 induces GLI1 degradation via the CRBN-dependent ubiquitin-proteasome pathway.
LRG20 potently inhibited tumor cell proliferation (HT-29, IC50=0.10 uM).
LRG20 (40 mg/kg) significantly suppressed tumor growth in an HT-29 xenograft model (TGI=70.89%) without observable toxicity.
| M.Wt | 665.24 | |
| Formula | C38H41ClN6O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Ya-Bing Xin, et al. Eur J Med Chem. 2026 Oct 31;321(Pt 3):119480.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright